Authority Details
The company received a final order from the ACIT Circle 7(1)(1). The disclosure specifically concerns an Order Giving Effect (OGE) to CIT-Appeal received for the GlaxoSmithKline assessment year 1984-85.
Order and Refund Dates
The OGE to CIT-Appeal was received on 27th January 2026. The actual refund of ₹52.00 crore was received in the company's bank account on 6th August 2026.
Financial Impact
The refund will result in interest income of ₹42.09 crore on the GlaxoSmithKline refund for assessment year 1984-85. This amount will be credited to the profit and loss account as income.